Revolutionizing Immunotherapy Research with 3D, Multiplexed Cryo-fluorescence Tomography
Dr. Matt Silva showcases the power of cryo-fluorescence tomography (CFT) in advancing immunotherapy research.
CBD’s Potential as an Anti-Cancer Agent
Chemotherapy treatment is incredibly difficult on patient wellbeing, but an unlikely plant-derived substance may yet improve the adverse side effects. In this blog, we discuss the use of CBD as a treatment for side effects like organ damage and drug resistance in cancer patients receiving chemotherapy.
Talking Real Science with Ellie Siebeneck
Ellie Siebeneck is one of 10 winners of the inaugural Scientist.com STEM Research NIL Award. In this episode, she discusses her passion for learning, mentorship and where the road lies ahead for her academic journey.
Cancer Immunotherapy: Viruses, Vaccines, and other Immuno-Oncology Treatments
In this blog post, current cancer immunotherapy treatments are discussed, as well as some future directions for this rapidly developing field.
Pancreatic Tumor and Therapy Monitoring
Join Dr. Srivalleesha Mallidi as she discusses advances in pancreatic cancer therapies using ultrasound-guided photoacoustic imaging.
Industry Insights with Amy Sheng on Nanobodies: An Important Tool for the Next Generation of Tumor Diagnostics and Therapeutics
Amy Sheng shares how nanobodies are emerging as important tools for tumor diagnosis and treatment.
Combination Therapy for Cancer Treatment
The combination of anti-cancer drugs, or combination therapy, has been hailed as a “cornerstone of cancer therapy” since it targets key pathways synergistically, thereby enhancing efficacy compared to monotherapies. This blog takes a look at a recent publication in Nature, which reported the effects of 2025 pairwise drug combinations in breast, colon, and pancreatic cell lines.
Cutting Edge Conversations: Discovering New Innovations in Oncology
Experts discuss progress in cancer research, including novel treatments, experimental therapies, and drug development.
#ExpertAnswers: Andrea Bonetto on the Musculoskeletal Complications of Cancer and its Treatments
Andrea Bonetto, PhD, answers questions from his recent webinar on how bone preservation directly impacts muscle size and function in cachexia, and contributes to new treatments for cancer.
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Join Dr. Danyi Wen as she describes a novel drug efficacy test using Patient Derived Xenograft (PDX) samples to measure drug efficacy and identify therapeutic candidates in personalized oncology treatments.
Musculoskeletal Complications of Cancer and its Treatments
Dr. Andrea Bonetto discusses the importance of musculoskeletal preservation in cancer treatment and shares evidence that bone preservation directly impacts muscle size and function in cachexia.
Cutting Edge Conversations: The Role of In Vivo Studies in Personalized Medicine
Grace Walton, Jonathan Nakashima, and Meghan Loy kick off Episode 1 of Scientist.com's Cutting Edge Conversations series with a presentation on fundamentals and future trends around the role of in vivo studies in personalized medicine
#ExpertAnswers: Marcela Maus on Inflammation and Immunophysiology
Dr. Marcela Maus discusses the components and technologies used in making a T cell product, important considerations for efficacy, and underlying mechanisms of toxicity and resistance.
Engineered T Cells for Cancer
Dr. Marcela Maus discusses CAR T Cell research, the components and technologies used in making a T cell product, important considerations for efficacy, and underlying mechanisms of toxicity and resistance.
White Paper – Advancing Cancer Treatments with ALZET® Osmotic Pumps
Success is in the delivery. This white paper from ALZET reviews applications and benefits of osmotic pumps for [...]
